4.32MMarket Cap0.28P/E (TTM)
0.5150High0.4970Low22.47KVolume0.5100Open0.4970Pre Close11.31KTurnover0.29%Turnover RatioLossP/E (Static)8.65MShares1.500052wk High0.45P/B3.90MFloat Cap0.364752wk Low--Dividend TTM7.81MShs Float115.2000Historical High--Div YieldTTM3.62%Amplitude0.3647Historical Low0.5030Avg Price1Lot Size
Exicure Stock Forum
BPC UPDATE 02/06/2024 ET
Pre-Market Updates
Exicure Inc (NASDAQ: XCUR) announced that it has licensed some of its patents to Bluejay Thearapeutics for advanced clinical development on the treatment of hepatitis. Bluejay will receive an exclusive license in the field of hepatitis to all of Exicure’s relevant patents. Bluejay paid Exicure an initial small, one-time payment after the execution of the deal.
$DMK Pharmaceuticals(DMK.US)$ $NanoString Technologies(NSTG.US)$ $Phunware(PHUN.US)$ $Exicure(XCUR.US)$ $Gorilla Technology(GRRR.US)$
📊⚡️📊
$Gorilla Technology(GRRR.US)$ $Exicure(XCUR.US)$ $Volcon(VLCN.US)$ $Biofrontera(BFRI.US)$ $Yield10 Bioscience(YTEN.US)$ $Atara Biotherapeutics(ATRA.US)$
📊⚡️📊
5 MINUTES AGO, 4:01 PM EST
VIA BUSINESSWIRE
No comment yet